|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
27
|
|
pubmed:dateCreated |
2005-7-14
|
|
pubmed:abstractText |
The clinical significance of co-infection of SENV-D among patients with chronic hepatitis C (CHC) and response of both viruses to combination therapy with high-dose interferon-alfa (IFN) plus ribavirin remain uncertain and are being investigated.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1007-9327
|
|
pubmed:author |
pubmed-author:ChangWen-YuWY,
pubmed-author:ChenShinn-CherngSC,
pubmed-author:ChuangWan-LongWL,
pubmed-author:DaiChia-YenCY,
pubmed-author:HouNei-JenNJ,
pubmed-author:HsiehMing-YenMY,
pubmed-author:HsiehMing-YuhMY,
pubmed-author:LeeLi-PoLP,
pubmed-author:LinZu-YauZY,
pubmed-author:WangLiang-YenLY,
pubmed-author:YuMing-LungML
|
|
pubmed:issnType |
Print
|
|
pubmed:day |
21
|
|
pubmed:volume |
11
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
4241-5
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:16015698-Adult,
pubmed-meshheading:16015698-Aged,
pubmed-meshheading:16015698-Antiviral Agents,
pubmed-meshheading:16015698-Circoviridae Infections,
pubmed-meshheading:16015698-Drug Therapy, Combination,
pubmed-meshheading:16015698-Female,
pubmed-meshheading:16015698-Hepatitis C, Chronic,
pubmed-meshheading:16015698-Humans,
pubmed-meshheading:16015698-Interferon-alpha,
pubmed-meshheading:16015698-Male,
pubmed-meshheading:16015698-Middle Aged,
pubmed-meshheading:16015698-Ribavirin
|
|
pubmed:year |
2005
|
|
pubmed:articleTitle |
Co-infection of SENV-D among chronic hepatitis C patients treated with combination therapy with high-dose interferon-alfa and ribavirin.
|
|
pubmed:affiliation |
Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung 807, Taiwan, China.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
